Moxisight LP Eye Drop is a combined topical ophthalmic solution containing Loteprednol etabonate (0.5% w/v) and Moxifloxacin (0.5% w/v). This medication is designed for the treatment of bacterial conjunctivitis and inflammation associated with various ophthalmic conditions. Loteprednol etabonate, a potent topical corticosteroid, provides anti-inflammatory action, reducing inflammation and discomfort. Moxifloxacin, a broad-spectrum quinolone antibiotic, targets a wide range of bacterial pathogens responsible for ocular infections. The co-administration of these active ingredients aims to manage the inflammation and infection effectively, promoting a speedier recovery and maintaining ocular health. However, it is crucial to follow the prescribed dosage and duration as overuse might lead to potential side effects or complications. Consult a healthcare professional for proper usage guidelines and potential interactions with other medications.